Comorbidities and Outcomes

Diabetes 2009 cohort, diabetes 2016 cohort, antihypertensive cohort, gout, heart failure, stroke, valvular heart disease, cardio-metabolic outcomes in PD-1/PD-L1 use. Anonymized datasets for research purposes (datasets last modified 1st Sept 2019). Disclaimer: These datasets were generated during the course of academic research conducted at the Faculty of Medicine, The Chinese University of Hong Kong, which received ethics approval by The Joint Chinese University of Hong Kong – New Territories East Cluster Clinical Research Ethics Committee and/or the Institutional Review Board of the University of Hong<br> Kong/Hospital Authority Hong Kong West Cluster of the Hospital Authority. They have been anonymised and are published for further advancement of medical research in full compliance with University Regulations and Policy on Dataset Deposit and Sharing. Access is for research purposes only. For additional information on local academic data deposition policies, see: https://libguides.lib.cuhk.edu.hk/RDM/dataset_deposit https://hub.hku.hk/researchdata/data.htm The use of these datasets should provide acknowledgements of such efforts by citing this DOI.本数据集涵盖2009年糖尿病队列、2016年糖尿病队列、抗高血压药物队列、痛风、心力衰竭、脑卒中、瓣膜性心脏病，以及程序性死亡受体1/程序性死亡受体配体1（PD-1/PD-L1）使用相关的心脏代谢结局。本数据集为供学术研究使用的匿名化数据集，最后修改时间为2019年9月1日。 免责声明：本数据集由香港中文大学医学院开展学术研究过程中生成，已获得香港中文大学–新界东联群临床研究伦理委员会及/或香港大学/医院管理局香港西医院联网机构审查委员会的伦理审查批准。所有数据集已完成匿名化处理，严格遵循香港中文大学关于数据集存储与共享的相关规定与政策，公开发布以推动医学研究的进一步发展。本数据集仅可用于学术研究用途。如需了解本地学术数据存储政策，可访问以下链接：https://libguides.lib.cuhk.edu.hk/RDM/dataset_deposit 及 https://hub.hku.hk/researchdata/data.htm。使用本数据集时，需通过引用本DOI以致谢相关研究工作。